Pulmonary volumes and capacities US Medical PG Practice Questions and MCQs
Practice US Medical PG questions for Pulmonary volumes and capacities. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Pulmonary volumes and capacities US Medical PG Question 1: A previously healthy 64-year-old woman comes to the physician because of a dry cough and progressively worsening shortness of breath for the past 2 months. She has not had fever, chills, or night sweats. She has smoked one pack of cigarettes daily for the past 45 years. She appears thin. Examination of the lung shows a prolonged expiratory phase and end-expiratory wheezing. Spirometry shows decreased FEV1:FVC ratio (< 70% predicted), decreased FEV1, and a total lung capacity of 125% of predicted. The diffusion capacity of the lung (DLCO) is decreased. Which of the following is the most likely diagnosis?
- A. Bronchiectasis
- B. Interstitial lung disease
- C. Chronic obstructive pulmonary disease (Correct Answer)
- D. Hypersensitivity pneumonitis
- E. Bronchial asthma
Pulmonary volumes and capacities Explanation: ***Chronic obstructive pulmonary disease***
- The patient's long history of **smoking (45 pack-years)**, **prolonged expiratory phase**, and **end-expiratory wheezing** are classic signs of airway obstruction.
- Spirometry findings of a **decreased FEV1:FVC ratio** (< 70% predicted), **decreased FEV1**, **increased total lung capacity (TLC)**, and **decreased DLCO** are all highly indicative of **emphysema**, a subtype of COPD.
*Bronchiectasis*
- While it shares symptoms like cough and SOB, **bronchiectasis** is characterized by permanent **dilatation of bronchi** and profuse, chronic **sputum production**, which is not mentioned here.
- Spirometry typically shows **obstructive patterns**, but the marked increase in TLC and decreased DLCO are more specific to emphysema.
*Interstitial lung disease*
- This condition primarily causes a **restrictive lung pattern**, meaning a decreased TLC and normal or increased FEV1:FVC ratio.
- The patient's **increased TLC** and **obstructive spirometry** rule out a purely restrictive process.
*Hypersensitivity pneumonitis*
- This is an inflammatory response to inhaled antigens, often presenting with **recurrent episodes** of fever, chills, and cough, and can lead to restrictive physiology.
- The patient lacks a history of specific **antigen exposure** and presents with an obstructive pattern and increased TLC.
*Bronchial asthma*
- While asthma shares obstructive features like wheezing and a decreased FEV1:FVC ratio, it is characterized by **reversibility** of airway obstruction and typically does not cause a significantly **elevated TLC** or **decreased DLCO** in uncomplicated cases.
- The patient's long smoking history points away from asthma as the primary diagnosis.
Pulmonary volumes and capacities US Medical PG Question 2: A 45-year-old man with a 15-pack-year smoking history is referred for pulmonary function testing. On physical exam, he appears barrel-chested and mildly overweight, but breathes normally. Which of the following tests will most accurately measure his total lung capacity?
- A. Exhaled nitric oxide
- B. Closed-circuit helium dilution
- C. Spirometry
- D. Body plethysmography (Correct Answer)
- E. Open-circuit nitrogen washout
Pulmonary volumes and capacities Explanation: ***Body plethysmography***
- This method accurately measures **total lung capacity (TLC)** by applying **Boyle's Law**, assessing pressure and volume changes within an enclosed chamber.
- It is superior to gas dilution methods for patients with **air trapping** or **poor ventilation distribution**, as it measures all gas in the chest, including trapped air.
*Exhaled nitric oxide*
- This test measures **airway inflammation**, particularly in conditions like asthma, but does not assess lung volumes.
- It is useful for monitoring treatment response and disease severity but does not provide information about **Total Lung Capacity (TLC)**.
*Closed-circuit helium dilution*
- This method estimates **lung volumes** by diluting a known concentration of helium, but it underestimates **TLC** in patients with significant **air trapping** because helium cannot equilibrate with unventilated areas.
- Given the patient's **barrel chest** suggestive of air trapping, this method would be less accurate for measuring his true TLC.
*Spirometry*
- Spirometry measures **forced vital capacity (FVC)** and **forced expiratory volume in one second (FEV1)**, which are dynamic lung volumes reflecting airflow limitation.
- It does not directly measure **Total Lung Capacity (TLC)** or **residual volume**, as it cannot measure the air remaining in the lungs after maximal exhalation.
*Open-circuit nitrogen washout*
- This method estimates **functional residual capacity (FRC)** by washing out nitrogen from the lungs with 100% oxygen, but like helium dilution, it can underestimate volumes in patients with **air trapping**.
- It provides an estimate of the gas that communicates with the airways, excluding any **trapped gas**.
Pulmonary volumes and capacities US Medical PG Question 3: A 40-year-old man with persistent moderate asthma presents for a pulmonary function test. His ratio of forced expiratory volume in one second (FEV1) to forced vital capacity (FVC) is 0.69, and his FEV1 is 65% of his predicted values. What other findings can be expected in the remainder of his pulmonary function test?
- A. Decreased diffusion capacity of carbon monoxide (DLCO)
- B. Decrease in FEV1 with albuterol
- C. Increase in fractional exhalation of nitric oxide (Correct Answer)
- D. Decrease in total lung capacity
- E. Increase in FEV1 with methacholine
Pulmonary volumes and capacities Explanation: ***Increase in fractional exhalation of nitric oxide***
- An increase in **fractional exhalation of nitric oxide (FeNO)** is a marker of **airway inflammation**, which is characteristic of asthma.
- This finding would further support the diagnosis of asthma in a patient with **obstructive lung disease** as indicated by the FEV1/FVC ratio and reduced FEV1.
*Decreased diffusion capacity of carbon monoxide (DLCO)*
- A decreased **DLCO** is typically seen in conditions affecting the **alveolar-capillary membrane**, such as emphysema or interstitial lung disease.
- In uncomplicated asthma, the **DLCO** is usually normal or even slightly increased due to increased pulmonary blood volume.
*Decrease in FEV1 with albuterol*
- **Albuterol** is a **short-acting beta-agonist (SABA)**, a bronchodilator that should *increase* FEV1 in a patient with reversible airway obstruction like asthma.
- A **decrease** in FEV1 after albuterol administration would be an unexpected and abnormal response, not consistent with asthma.
*Decrease in total lung capacity*
- A **decrease in total lung capacity (TLC)** is characteristic of **restrictive lung diseases**, where lung expansion is limited.
- Asthma is an **obstructive lung disease**, and patients often exhibit **air trapping** and **hyperinflation**, leading to a *normal or increased* TLC, not a decrease.
*Increase in FEV1 with methacholine*
- **Methacholine** is a **bronchoconstrictor** used in bronchial challenge tests to *induce* bronchospasm and a *decrease* in FEV1 in asthmatic patients.
- An **increase** in FEV1 with methacholine would be contrary to its pharmacological effect and the expected response in asthma.
Pulmonary volumes and capacities US Medical PG Question 4: A 22-year-old woman presents to the emergency department with a chief concern of shortness of breath. She was hiking when she suddenly felt unable to breathe and had to take slow deep breaths to improve her symptoms. The patient is a Swedish foreign exchange student and does not speak any English. Her past medical history and current medications are unknown. Her temperature is 99.5°F (37.5°C), blood pressure is 127/68 mmHg, pulse is 120/min, respirations are 22/min, and oxygen saturation is 90% on room air. Physical exam is notable for poor air movement bilaterally and tachycardia. The patient is started on treatment. Which of the following best describes this patient's underlying pathology?
FEV1 = Forced expiratory volume in 1 second
FVC = Forced vital capacity
DLCO = Diffusing capacity of carbon monoxide
- A. Increased FVC
- B. Increased FEV1
- C. Increased FEV1/FVC
- D. Decreased airway tone
- E. Normal DLCO (Correct Answer)
Pulmonary volumes and capacities Explanation: ***Normal DLCO***
- This patient presents with an acute exacerbation of what is likely **asthma**, showing symptoms of **shortness of breath**, **tachycardia**, poor air movement bilaterally, and improvement with slow deep breaths. **Asthma** characteristically affects the airways and not the alveoli, thus the **diffusing capacity of carbon monoxide (DLCO)**, which measures gas exchange across the alveolar-capillary membrane, would be expected to be normal.
- In asthma, the primary problem is **bronchoconstriction** and **airway inflammation**, which restricts airflow but does not typically impair the diffusion of gases like carbon monoxide across the alveolar-capillary membrane.
*Increased FVC*
- **Forced vital capacity (FVC)** is often normal or even slightly reduced in asthma due to **air trapping** and early airway closure, not increased.
- An increased FVC is usually not associated with obstructive lung diseases like asthma but could potentially be seen in conditions where lung volumes are pathologically large, which is not the case here.
*Increased FEV1*
- **Forced expiratory volume in 1 second (FEV1)** is typically **decreased** in obstructive lung diseases like asthma due to **airflow limitation**.
- An increased FEV1 would indicate better-than-average expiratory flow, which contradicts the symptoms of shortness of breath and poor air movement in this patient.
*Increased FEV1/FVC*
- The **FEV1/FVC ratio** is characteristically **decreased** in obstructive lung diseases like asthma, indicating that a disproportionately smaller amount of air can be exhaled in the first second relative to the total forced vital capacity.
- An increased FEV1/FVC ratio would be a sign of a restrictive lung disease or normal lung function, not an exacerbation of an obstructive process.
*Decreased airway tone*
- The underlying pathology in asthma is typically **bronchoconstriction**, which means an **increased airway tone** and narrowing of the airways, rather than decreased.
- Decreased airway tone would imply bronchodilation, which would alleviate, not cause, the patient's symptoms of shortness of breath and poor air movement.
Pulmonary volumes and capacities US Medical PG Question 5: Which of the following physiologic changes decreases pulmonary vascular resistance (PVR)?
- A. Inhaling the inspiratory reserve volume (IRV)
- B. Exhaling the entire vital capacity (VC)
- C. Exhaling the expiratory reserve volume (ERV)
- D. Breath holding maneuver at functional residual capacity (FRC)
- E. Inhaling the entire vital capacity (VC) (Correct Answer)
Pulmonary volumes and capacities Explanation: ***Inhaling the entire vital capacity (VC)***
- As lung volume increases from FRC to TLC (which includes inhaling the entire VC), alveolar vessels are **stretched open**, and extra-alveolar vessels are **pulled open** by the increased radial traction, leading to a decrease in PVR.
- This **maximizes the cross-sectional area** of the pulmonary vascular bed, lowering resistance.
*Inhaling the inspiratory reserve volume (IRV)*
- While inhaling IRV increases lung volume, it's not the maximal inspiration of the entire VC where **PVR is typically at its lowest**.
- PVR continues to decrease as lung volume approaches total lung capacity (TLC).
*Exhaling the entire vital capacity (VC)*
- Exhaling the entire vital capacity leads to very low lung volumes, where PVR significantly **increases**.
- At low lung volumes, **alveolar vessels become compressed** and extra-alveolar vessels **narrow**, increasing resistance.
*Exhaling the expiratory reserve volume (ERV)*
- Exhaling the ERV results in a lung volume below FRC, which causes a **marked increase in PVR**.
- This is due to the **compression of alveolar vessels** and decreased radial traction on extra-alveolar vessels.
*Breath holding maneuver at functional residual capacity (FRC)*
- At FRC, the PVR is at an **intermediate level**, not its lowest.
- This is the point where the opposing forces affecting alveolar and extra-alveolar vessels are somewhat balanced, but not optimized for minimal resistance.
Pulmonary volumes and capacities US Medical PG Question 6: A 60-year-old woman with a history of emphysema has been referred by her pulmonologist for follow-up pulmonary function testing. During the test, the patient reaches a point where her airway pressure is equal to the atmospheric pressure. Which of the following is most likely to be found during this respiratory state?
- A. Pulmonary vascular resistance is at a maximum
- B. Transmural pressure of the lung-chest wall system is at a maximum
- C. Transmural pressure of the chest wall is at a minimum
- D. Pulmonary vascular resistance is at a minimum (Correct Answer)
- E. Transmural pressure of the lung-chest wall system is at a minimum
Pulmonary volumes and capacities Explanation: ***Pulmonary vascular resistance is at a minimum***
- When airway pressure equals atmospheric pressure during a pulmonary function test, the lungs are at **functional residual capacity (FRC)** or resting state.
- At FRC, **pulmonary vascular resistance (PVR)** is at its lowest point due to the optimal balance between alveolar and extra-alveolar vessel compression/distension.
- Extra-alveolar vessels are compressed at low lung volumes, while alveolar vessels are compressed at high lung volumes. At FRC, both are optimally distended, resulting in **minimal PVR**.
*Pulmonary vascular resistance is at a maximum*
- PVR increases at very low lung volumes (due to extra-alveolar vessel compression) and very high lung volumes (due to alveolar vessel compression).
- The resting state (airway pressure equals atmospheric pressure) corresponds to FRC, where PVR is **minimal, not maximal**.
*Transmural pressure of the lung-chest wall system is at a maximum*
- Transmural pressure of the lung-chest wall system represents the pressure difference across the entire respiratory system.
- This pressure is higher during inspiration or forced expiration when the system is stretched or compressed.
- At FRC (airway pressure equals atmospheric pressure), the system is at **resting equilibrium**, not at maximal transmural pressure.
*Transmural pressure of the chest wall is at a minimum*
- Transmural pressure across the chest wall is the difference between intrapleural pressure and atmospheric pressure.
- This pressure is not at a minimum when airway pressure equals atmospheric pressure.
- Chest wall transmural pressure is actually minimal near **residual volume (RV)**, where the chest wall recoils inward most strongly.
*Transmural pressure of the lung-chest wall system is at a minimum*
- Transmural pressure of the lung-chest wall system reflects the elastic recoil forces of the combined system.
- At FRC (airway pressure equals atmospheric pressure), elastic recoil forces are balanced at equilibrium, but transmural pressure is **not at a minimum**—it represents the neutral resting state.
Pulmonary volumes and capacities US Medical PG Question 7: A 15-year-old boy and his mother were referred to a pulmonology clinic. She is concerned that her son is having some breathing difficulty for the past few months, which is aggravated with exercise. The family is especially concerned because the patient’s older brother has cystic fibrosis. The past medical history is noncontributory. Today, the vital signs include: blood pressure 119/80 mm Hg, heart rate 90/min, respiratory rate 17/min, and temperature 37.0°C (98.6°F). On physical exam, he appears well-developed and well-nourished. The heart has a regular rate and rhythm, and the lungs are clear to auscultation bilaterally. During the exam, he is brought into a special room to test his breathing. A clamp is placed on his nose and he is asked to take in as much air as he can, and then forcefully expire all the air into a spirometer. The volume of expired air represents which of the following?
- A. Tidal volume
- B. Total lung capacity
- C. Functional residual capacity
- D. Expiratory reserve volume
- E. Vital capacity (Correct Answer)
Pulmonary volumes and capacities Explanation: ***Vital capacity***
- **Vital capacity (VC)** is the maximum volume of air exhaled after a maximal inspiration. The maneuver described ("take in as much air as he can, and then forcefully expire all the air") directly measures vital capacity.
- VC includes the **tidal volume (TV)**, **inspiratory reserve volume (IRV)**, and **expiratory reserve volume (ERV)**.
*Tidal volume*
- **Tidal volume (TV)** is the volume of air inspired or expired with a normal breath, not the maximal forceful expiration described.
- It represents the usual volume of air exchanged during quiet breathing.
*Total lung capacity*
- **Total lung capacity (TLC)** is the maximum volume of air that the lungs can hold after a maximal inspiration, including the residual volume.
- This cannot be measured directly by spirometry alone, as it includes the **residual volume** which is the air remaining in the lungs after maximal expiration.
*Functional residual capacity*
- **Functional residual capacity (FRC)** is the volume of air remaining in the lungs after a normal, quiet expiration.
- Like TLC and residual volume, FRC cannot be measured directly by standard spirometry.
*Expiratory reserve volume*
- **Expiratory reserve volume (ERV)** is the maximum volume of air that can be *additionally* exhaled after a normal exhalation.
- The patient was asked to expire all the air after a maximal inspiration, which is a measure of vital capacity, not just ERV.
Pulmonary volumes and capacities US Medical PG Question 8: A 55-year-old man with recurrent pneumonia comes to the physician for a follow-up examination one week after hospitalization for pneumonia. He feels well but still has a productive cough. He has smoked 1 pack of cigarettes daily for 5 years. His temperature is 36.9°C (98.4°F) and respirations are 20/min. Cardiopulmonary examination shows coarse crackles at the right lung base. Microscopic examination of a biopsy specimen of the right lower lung parenchyma shows proliferation of clustered, cuboidal, foamy-appearing cells. These cells are responsible for which of the following functions?
- A. Mucus secretion
- B. Cytokine release
- C. Lecithin production (Correct Answer)
- D. Toxin degradation
- E. Gas diffusion
Pulmonary volumes and capacities Explanation: ***Lecithin production***
- The description of **clustered, cuboidal, foamy-appearing cells** in the lung parenchyma strongly suggests **Type II pneumocytes**.
- **Type II pneumocytes** are primarily responsible for producing and secreting **pulmonary surfactant**, which is rich in **lecithin (phosphatidylcholine)**, to reduce surface tension in the alveoli.
*Mucus secretion*
- **Goblet cells** and **submucosal glands** in the airways are responsible for mucus secretion, not the alveolar cells described.
- Mucus functions to trap particles and pathogens, preventing them from reaching the alveoli.
*Cytokine release*
- While various lung cells, including macrophages and epithelial cells, can release cytokines in response to inflammation or infection, it is not the primary defining function of Type II pneumocytes.
- **Cytokine release** is a broad immune response, not specific to the unique morphology and function described.
*Toxin degradation*
- The liver and kidneys are the primary organs for **toxin degradation** and excretion, though some detoxification can occur in the lungs.
- This function is not characteristic of **Type II pneumocytes**, which are focused on surfactant production and alveolar repair.
*Gas diffusion*
- **Gas diffusion** primarily occurs across the **Type I pneumocytes** (squamous alveolar cells) and the capillary endothelial cells due to their thinness and large surface area.
- **Type II pneumocytes** are thicker and less involved in direct gas exchange.
Pulmonary volumes and capacities US Medical PG Question 9: A 2500-g (5-lb 8-oz) female newborn delivered at 37 weeks' gestation develops rapid breathing, grunting, and subcostal retractions shortly after birth. Despite appropriate lifesaving measures, the newborn dies 2 hours later. Autopsy shows bilateral renal agenesis. Which of the following is the most likely underlying cause of this newborn's respiratory distress?
- A. Displacement of intestines into the pleural cavity
- B. Injury to the diaphragmatic innervation
- C. Collapse of the supraglottic airway
- D. Decreased amniotic fluid ingestion
- E. Pulmonary hypoplasia (Correct Answer)
Pulmonary volumes and capacities Explanation: ***Pulmonary hypoplasia***
- **Bilateral renal agenesis** (Potter sequence) leads to severely reduced or absent fetal urine production, causing **oligohydramnios**.
- **Oligohydramnios** prevents normal lung development, resulting in **pulmonary hypoplasia**, which is the primary cause of respiratory distress and death in these newborns.
*Displacement of intestines into the pleural cavity*
- This describes a **congenital diaphragmatic hernia**, which can cause respiratory distress due to lung compression.
- However, the autopsy finding of **bilateral renal agenesis** points to Potter sequence as the underlying cause, not a diaphragmatic hernia.
*Injury to the diaphragmatic innervation*
- Injury to the phrenic nerve (diaphragmatic innervation) can lead to **diaphragmatic paralysis** and respiratory distress.
- This is not directly related to **bilateral renal agenesis** or the characteristic findings of Potter sequence.
*Collapse of the supraglottic airway*
- This describes conditions like **laryngomalacia** or other upper airway obstructions.
- While these can cause respiratory distress, they are not typically linked to **bilateral renal agenesis** or the systemic consequences of **oligohydramnios**.
*Decreased amniotic fluid ingestion*
- Fetal swallowing of amniotic fluid is important for gastrointestinal development and recycling of fluid.
- However, decreased ingestion primarily affects **gastrointestinal maturation** and amniotic fluid volume (if there is a swallowing problem), not directly lung development in the way oligohydramnios from renal agenesis does.
Pulmonary volumes and capacities US Medical PG Question 10: A 57-year-old man presents to the clinic for a chronic cough over the past 4 months. The patient reports a productive yellow/green cough that is worse at night. He denies any significant precipitating event prior to his symptoms. He denies fever, chest pain, palpitations, weight changes, or abdominal pain, but endorses some difficulty breathing that waxes and wanes. He denies alcohol usage but endorses a 35 pack-year smoking history. A physical examination demonstrates mild wheezes, bibasilar crackles, and mild clubbing of his fingertips. A pulmonary function test is subsequently ordered, and partial results are shown below:
Tidal volume: 500 mL
Residual volume: 1700 mL
Expiratory reserve volume: 1500 mL
Inspiratory reserve volume: 3000 mL
What is the functional residual capacity of this patient?
- A. 4500 mL
- B. 2000 mL
- C. 2200 mL
- D. 3200 mL (Correct Answer)
- E. 3500 mL
Pulmonary volumes and capacities Explanation: ***3200 mL***
- The **functional residual capacity (FRC)** is the volume of air remaining in the lungs after a normal expiration.
- It is calculated as the sum of the **expiratory reserve volume (ERV)** and the **residual volume (RV)**. In this case, 1500 mL (ERV) + 1700 mL (RV) = 3200 mL.
*4500 mL*
- This value represents the sum of the **inspiratory reserve volume (3000 mL)** and the **residual volume (1700 mL)**, which does not correspond to a standard lung volume or capacity.
- It does not logically relate to the definition of functional residual capacity.
*2000 mL*
- This value represents the sum of the **tidal volume (500 mL)** and the **expiratory reserve volume (1500 mL)**, which is incorrect for FRC.
- This would represent the inspiratory capacity minus the inspiratory reserve volume, which is not a standard measurement used in pulmonary function testing.
*2200 mL*
- This value could be obtained by incorrectly adding the **tidal volume (500 mL)** and the **residual volume (1700 mL)**, which is not the correct formula for FRC.
- This calculation represents a miscombination of lung volumes that does not correspond to any standard pulmonary capacity measurement.
*3500 mL*
- This value is the sum of the **tidal volume (500 mL)**, the **expiratory reserve volume (1500 mL)**, and the **residual volume (1700 mL)**.
- This would represent the FRC plus the tidal volume, which is not a standard measurement and does not represent the functional residual capacity.
More Pulmonary volumes and capacities US Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
